Eli Lilly has struck a deal to buy Crispr gene-editing start-up Verve Therapeutics for up to $1.3bn, the latest acquisition ...

Turning a $10,000 investment into $1 million represents a financial dream for many — a 100x return that would require an ...

Japanese researchers have successfully eliminated the extra chromosome responsible for Down syndrome using CRISPR gene ...

For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while ...

A team at Kobe University has created a game-changing resource for autism research: 63 mouse embryonic stem cell lines, each ...

Crispr Therapeutics AG leverages CASGEVY's rollout, a robust pipeline in cardiovascular, oncology, & partnerships to large ...

CRISPR Gene editing therapy is used for the first time in living humans with amazing results.

After 307 days at CHOP, KJ was dressed in what early studies suggest are the world’s smallest and cutest graduation ...

Researchers from Tel Aviv University have developed a genetic editing method tailored to crop plants, which has influenced ...

Amid a challenging gene editing climate, partnerships between researchers, regulators, and industry remain crucial for ...